Literature DB >> 19861003

Bacille Calmette-Guérin vaccine-related disease in HIV-infected children: a systematic review.

P Azzopardi1, C M Bennett, S M Graham, T Duke.   

Abstract

OBJECTIVE: To describe the characteristics and risk of bacille Calmette-Guérin (BCG) vaccine related disease in human immunodeficiency virus (HIV) infected infants.
METHODS: Systematic literature review of articles published from 1950 to April 2009 in the English language. We identified all microbiologically confirmed cases of disseminated BCG disease in vertically HIV-infected children reported in the literature.
RESULTS: Sixteen observational studies and 11 case reports/series were included. Observational studies suffered from high rates of loss to follow-up and death. Loco-regional BCG disease was reported in both HIV-infected and non-infected children. Disseminated BCG disease was reported only in children with immunodeficiency and only in studies employing sophisticated laboratory techniques. Sixty-nine cases of disseminated BCG were identified in the literature: 47 cases were reported in six observational studies, the majority (41/47) from the Western Cape of South Africa. A Brazilian cohort study reported no cases of disseminated BCG amongst 66 HIV-infected children observed over a 7-year period. A recent South African surveillance study reported 32 cases of disseminated BCG over a 3-year period, estimating the risk of disseminated BCG to be 992 per 100,000 vaccinations in HIV-infected children. Few cases of severe disseminated TB were reported in the cohort studies among HIV-infected children vaccinated with BCG.
CONCLUSION: Data on the risk of BCG vaccination in HIV-infected children are limited. Targeted surveillance for BCG complications employing sophisticated diagnostic techniques is required to inform vaccination policy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19861003

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  17 in total

1.  Mycobacterium bovis BCG-Russia clinical isolate with noncanonical spoligotyping profile.

Authors:  Igor Mokrousov; Anna Vyazovaya; Yulia Potapova; Boris Vishnevsky; Tatiana Otten; Olga Narvskaya
Journal:  J Clin Microbiol       Date:  2010-09-29       Impact factor: 5.948

2.  Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitis.

Authors:  H Rabie; A Violari; T Duong; S A Madhi; D Josipovic; S Innes; E Dobbels; E Lazarus; R Panchia; A G Babiker; D M Gibb; M F Cotton
Journal:  Int J Tuberc Lung Dis       Date:  2011-09       Impact factor: 2.373

3.  Single nucleotide polymorphisms in the Mycobacterium bovis genome resolve phylogenetic relationships.

Authors:  Deepti Joshi; N Beth Harris; Ray Waters; Tyler Thacker; Barun Mathema; Barry Krieswirth; Srinand Sreevatsan
Journal:  J Clin Microbiol       Date:  2012-09-19       Impact factor: 5.948

Review 4.  Malnutrition and vaccination in developing countries.

Authors:  Andrew J Prendergast
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-19       Impact factor: 6.237

5.  Comparative evaluation of MPT83 (Rv2873) for T helper-1 cell reactivity and identification of HLA-promiscuous peptides in Mycobacterium bovis BCG-vaccinated healthy subjects.

Authors:  Abu S Mustafa
Journal:  Clin Vaccine Immunol       Date:  2011-08-18

Review 6.  Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years.

Authors:  Edwin J Asturias; Melinda Wharton; Robert Pless; Noni E MacDonald; Robert T Chen; Nicholas Andrews; David Salisbury; Alexander N Dodoo; Kenneth Hartigan-Go; Patrick L F Zuber
Journal:  Vaccine       Date:  2016-05-16       Impact factor: 3.641

Review 7.  Current status of new tuberculosis vaccine in children.

Authors:  Yu Pang; Aihua Zhao; Chad Cohen; Wanli Kang; Jie Lu; Guozhi Wang; Yanlin Zhao; Suhua Zheng
Journal:  Hum Vaccin Immunother       Date:  2016-03-22       Impact factor: 3.452

8.  Prophylactic effect of a therapeutic vaccine against TB based on fragments of Mycobacterium tuberculosis.

Authors:  Cristina Vilaplana; Olga Gil; Neus Cáceres; Sergio Pinto; Jorge Díaz; Pere-Joan Cardona
Journal:  PLoS One       Date:  2011-05-24       Impact factor: 3.240

9.  Malaria infections do not compromise vaccine-induced immunity against tuberculosis in mice.

Authors:  Marcela Parra; Steven C Derrick; Amy Yang; Jinhua Tian; Kristopher Kolibab; Miranda Oakley; Liyanage P Perera; William R Jacobs; Sanjai Kumar; Sheldon L Morris
Journal:  PLoS One       Date:  2011-12-19       Impact factor: 3.240

10.  Rifampin-resistant Mycobacterium bovis BCG-induced disease in HIV-infected infant, Vietnam.

Authors:  Duc Nguyen Hong; Mai Nguyet Thu Huyen; Nguyen Thi Ngoc Lan; Nguyen Huy Duong; Vi Vi Nguyen Ngo; Duong Tran Ngoc; Khanh Truong Huu; Tuyen Nguyen; Viet Do Chau; Oliver Marcy; Philippe Van de Perre; Anne-Laure Bañuls; Sylvain Godreuil
Journal:  Emerg Infect Dis       Date:  2013-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.